awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35592524-39596BAF-1FF3-4920-9738-3D1ACB7491EE
Q35592524-39596BAF-1FF3-4920-9738-3D1ACB7491EE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35592524-39596BAF-1FF3-4920-9738-3D1ACB7491EE
Short term efficacy and safety in glaucoma patients changed to the latanoprost 0.005%/timolol maleate 0.5% fixed combination from monotherapies and adjunctive therapies.
P2860
Q35592524-39596BAF-1FF3-4920-9738-3D1ACB7491EE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35592524-39596BAF-1FF3-4920-9738-3D1ACB7491EE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
03e235025acacf089d6db37e28efd1c3cffde24f
P2860
Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.